Biocon Ltd (BIOCON) — Announcement | 8 September 2026 (2 announcements)

Biocon announced a 10-year supply agreement for Pertuzumab in Brazil through a partnership with Bahiafarma and Bionovis, securing exclusive access to Brazil's public healthcare market and potential milestone payments and revenue sharing over a decade, marking a strategic expansion into the Brazilian oncology market.

Biocon announced its upcoming investor meetings schedule, including a Sep 11 roadshow in Mumbai, to engage analysts and institutional investors. The company emphasized no UPSI will be shared during these sessions, with details available on its website. This proactive outreach aims to enhance transparency and strengthen relationships with key stakeholders ahead of potential market discussions.